National Health Investors
214 hedge funds and large institutions have $2.24B invested in National Health Investors in 2017 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 24 closing their positions.
38% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 24
4% more funds holding
Funds holding: 206 → 214 (+8)
4% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 72
0.58% less ownership
Funds ownership: 72.05% → 71.47% (-0.58%)
2% less capital invested
Capital invested by funds: $2.28B → $2.24B (-$46.6M)
76% less call options, than puts
Call options by funds: $2.28M | Put options by funds: $9.29M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$22.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.4M |
| 3 |
BlackRock
New York
|
+$14.2M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$10.6M |
| 5 |
Renaissance Technologies
New York
|
+$8.54M |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$30.3M |
| 2 |
Millennium Management
New York
|
-$21.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.4M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.42M |
NHI Hedge Fund Activity: Q4 2017 in Review
214 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q4 2017, worth a combined $2.24B — down 2% from $2.28B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new NHI positions and 24 closed out — a net gain of 9 holders — while 75 added to existing stakes and 72 trimmed.
The largest buyer was Invesco, adding an estimated $22.1M. The largest seller was JP Morgan Chase, cutting an estimated $30.3M.
- 214 institutional investors held National Health Investors (NHI) as of Q4 2017, up from 206 in Q3 2017.
- Funds reported $2.24B of National Health Investors stock for Q4 2017, down 2% quarter-over-quarter.
- 33 funds opened new National Health Investors positions in Q4 2017 and 24 closed out, a net change of +9 holders.
- The largest National Health Investors buyer in Q4 2017 was Invesco, an estimated $22.1M added.
- The largest National Health Investors seller in Q4 2017 was JP Morgan Chase, an estimated $30.3M sold.
Based on aggregated 13F filings for Q4 2017.